A functional genetic approach suggests a novel interaction between the human immunodeficiency virus type 1 (HIV-1) Tat protein and HIV-1 TAR RNA in vivo

被引:9
|
作者
Lund, LH
Wahren, B
Garcia-Blanco, MA
机构
[1] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[3] Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17182 Solna, Sweden
[4] Karolinska Inst, Swedish Inst Infect Dis Control, S-17182 Solna, Sweden
来源
关键词
D O I
10.1099/vir.0.18645-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) Tat and human Cyclin T1 form a complex and together recognize the viral TAR RNA element with specificity. Using HIV-1/equine infectious anaemia virus TAR chimeras, we show that in addition to the well-characterized interaction with the bulge, Tat recognizes the distal stem and the loop of TAR. These data support previously proposed, but unproven, molecular models.
引用
收藏
页码:603 / 606
页数:4
相关论文
共 50 条
  • [31] Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection
    Sei, S
    Sandelli, SL
    Theofan, G
    Ratto-Kim, S
    Kumagai, M
    Loomis-Price, LD
    Cox, JH
    Jarosinski, P
    Walsek, CM
    Brouwers, P
    Venzon, DJ
    Xu, J
    Pizzo, PA
    Moss, RB
    Robb, ML
    Wood, LV
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03): : 626 - 640
  • [32] BLOCK OF HIV-1 INFECTION BY A COMBINATION OF ANTISENSE TAT RNA AND TAR DECOYS - A STRATEGY FOR CONTROL OF HIV-1
    CHANG, HK
    GENDELMAN, R
    LISZIEWICZ, J
    GALLO, RC
    ENSOLI, B
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S22 - S22
  • [33] BLOCK OF HIV-1 INFECTION BY A COMBINATION OF ANTISENSE TAT RNA AND TAR DECOYS - A STRATEGY FOR CONTROL OF HIV-1
    CHANG, HK
    GENDELMAN, R
    LISZIEWICZ, J
    GALLO, RC
    ENSOLI, B
    GENE THERAPY, 1994, 1 (03) : 208 - 216
  • [34] Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat
    He, GC
    Margolis, DM
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (09) : 2965 - 2973
  • [35] Functional characterization of HIV-1 Tat exon-1 variants from North India and their implications on HIV-1 transactivation and TAR interaction
    Larance Ronsard
    VG Ramachandran
    Akhil C Banerjea
    BMC Infectious Diseases, 14 (Suppl 3)
  • [36] The human immunodeficiency virus type-1 (HIV-1) Tat protein and bcl-2 gene expression
    Zauli, G
    Gibellini, D
    LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 551 - 560
  • [37] The Vif protein of human immunodeficiency virus type 1 (HIV-1): Enigmas and solutions
    Baraz, L
    Kotler, M
    CURRENT MEDICINAL CHEMISTRY, 2004, 11 (02) : 221 - 231
  • [38] HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 (HIV-1) AND THE BRAIN
    GRANT, I
    HEATON, RK
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1990, 58 (01) : 22 - 30
  • [39] The immune response to human immunodeficiency virus type 1 (HIV-1)
    Turnbull, E
    Borrow, P
    MOLECULAR PATHOGENESIS OF VIRUS INFECTIONS, 2005, 64 : 23 - 89
  • [40] Robust growth of human immunodeficiency virus type 1 (HIV-1)
    Kim, H
    Yin, J
    BIOPHYSICAL JOURNAL, 2005, 89 (04) : 2210 - 2221